C Ann.indd

Similar documents
丽珠医药集团股份有限公司

丽珠医药集团股份有限公司

Microsoft Word _4

郑州大学(下).doc

厨房小知识(六)


游戏攻略大全(五十).doc

金融英语证书考试大纲

健康知识(二)

中南财经大学(二).doc

根据学校教学工作安排,2011年9月19日正式开课,也是我校迁址蓬莱的第一学期开学

山东大学(一).doc

主 编 : 杨 林 副 主 编 : 张 新 民 邹 兰 曹 纯 纯 周 秋 婷 李 雅 清 黄 囡 囡 评 审 顾 问 : 杨 林 张 新 民 评 审 : 张 新 民 邹 兰 曹 纯 纯 周 秋 婷 李 雅 清 黄 囡 囡 李 忆 萍 徐 如 雪 文 字 编 辑 : 曹 纯 纯 邹 兰 李 雅 清

最新文物管理执法全书(十四).doc

园林常识(二).doc

前 言 二 一 六 年 四 月 四 日, 兒 童 節, 誕 生 了 一 件 美 事 : 中 國 作 家 曹 文 軒 在 意 大 利 博 洛 尼 亞 國 際 童 書 展 榮 獲 國 際 安 徒 生 文 學 獎, 是 該 獎 創 設 六 十 年 來, 第 一 位 摘 桂 的 中 國 作 家, 意 義 重

湖 南 科 技 大 学

2009 陳 敦 德

切 实 加 强 职 业 院 校 学 生 实 践 能 力 和 职 业 技 能 的 培 养 周 济 在 职 业 教 育 实 训 基 地 建 设 工 作 会 议 上 的 讲 话 深 化 教 育 教 学 改 革 推 进 体 制 机 制 创 新 全 面 提 高 高 等 职 业 教 育 质 量 在

鸽子(三)

园林植物卷(十七).doc

临床手术应用(三)

Microsoft Word mpc-min-chi.doc

( ) 1

穨cwht.PDF

(Microsoft Word - outline for Genesis 9\243\2721\243\25529.doc)

Microsoft Word - om388-rnt _excl Items 16 & 38_ _final_for uploading_.doc

公務員懲戒法實務及新制

大小通吃-糖尿病

NCL( )版中文版和区分表修改内容

中華基督教會國語堂

Microsoft Word - Some_regulation_on_drug_bulk_pruchasing.doc

項 訴 求 在 考 慮 到 整 體 的 財 政 承 擔 以 及 資 源 分 配 的 公 平 性 下, 政 府 採 取 了 較 簡 單 直 接 的 一 次 性 減 稅 和 增 加 免 稅 額 方 式, 以 回 應 中 產 家 庭 的 不 同 訴 求 ( 三 ) 取 消 外 傭 徵 費 6. 行 政 長

(f) (g) (h) (ii) (iii) (a) (b) (c) (d) 208

Microsoft Word - 08 单元一儿童文学理论

南華大學數位論文

Microsoft Word 一年級散文教案.doc

第三章

1. 本文首段的主要作用是 A. 指出 異蛇 的藥用功效 說明 永之人爭奔走焉 的原因 B. 突出 異蛇 的毒性 為下文 幾死者數矣 作鋪墊 C. 交代以蛇賦稅的背景 引起下文蔣氏有關捕蛇的敘述 2. 本文首段從三方面突出蛇的 異 下列哪一項不屬其中之一 A. 顏色之異 B. 動作之異 C. 毒性之

Microsoft Word - 發布版---規範_全文_.doc

概 述 随 着 中 国 高 等 教 育 数 量 扩 张 目 标 的 逐 步 实 现, 提 高 教 育 质 量 的 重 要 性 日 益 凸 显 发 布 高 校 毕 业 生 就 业 质 量 年 度 报 告, 是 高 等 学 校 建 立 健 全 就 业 状 况 反 馈 机 制 引 导 高 校 优 化 招

鱼类丰产养殖技术(二).doc

疾病诊治实务(一)

名人养生.doc

<4D F736F F D2040B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8735FA7F5ABD8BFB3B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8732E646F63>


中老年保健必读(十).doc

27 i

% % ,542 12,336 14,53 16,165 18,934 22,698 25, ,557 7,48 8,877 11, 13,732 17,283 22,

穨ecr1_c.PDF

穨2005_-c.PDF

北京理工大学.doc

尲㐵.⸮⸮⸮⸮⸮

果树高产栽培技术(一).doc

物质结构_二_.doc

第一節 研究動機與目的

水力发电(九)

中国古代文学家(八).doc

景观植物(一)

Microsoft Word - 目录.doc

园林植物卷(三).doc

19q indd

厨房小知识_一_

中南财经大学(七).doc

赵飞燕外传、四美艳史演义

Microsoft Word - edu-re~1.doc

Transcription:

LIVZON PHARMACEUTICAL GROUP INC.* 1513 Livzon Pharmaceutical Group Inc.* 1

1 1.1 (www.hkexnews.hk)(www.livzon.com.cn) H 1.2 1.3 1.4 20142014 10 1103 1.5 2

2 2.1 A H 1 H 2 000513 01513299902 3 1 2014116BH B200513B 23 BHH 2.2 (0756) 8135888 (0756) 8135888 (0756) 8886002 (0756) 8886002 yangliang2014@livzon.com.cn wangshuguang2008@livzon.com.cn 132 3

3 3.1 2[2014]14 41 [2014]16 2014112 (1) 2 2014 10,041,559.76 82,253,108.84 92,294,668.60 123,764,866.29-82,253,108.84 41,511,757.45 4

2 2013 10,612,859.66 82,253,108.84 92,865,968.50 120,961,203.38 82,253,108.84 38,708,094.54 (2) 2 2014 10,041,559.76 81,753,108.84 91,794,668.60 1,712,566,612.12 81,753,108.84 1,630,813,503.28 5

2 2013 10,612,859.66 81,753,108.84 92,365,968.50 1,660,096,199.25 81,753,108.84 1,578,343,090.41 3.2 2014 2013 (%) 2012 2011 2010 5,544,233.78 4,618,680.04 20.04% 3,943,525.31 3,162,915.29 2,726,718.90 515,978.43 487,502.35 5.84% 441,671.52 359,369.88 418,180.83 463,031.47 462,159.19 0.19% 396,190.25 341,610.16 392,186.22 717,393.89 439,986.53 63.05% 593,964.66 708,201.34 633,296.31 652,025.03 628,940.45 3.67% 560,312.74 463,151.23 533,667.30 6

2014 2013 (%) 2012 2011 2010 7,302,605.06 6,566,006.12 11.22% 5,633,753.96 4,602,908.98 3,661,991.63 3,220,183.53 2,961,486.64 8.74% 2,453,634.71 1,591,291.15 1,022,841.04 3,696,516.57 3,344,648.58 10.52% 3,008,015.81 2,843,169.71 2,517,438.11 295,721.85 295,721.85 0.00% 295,721.85 295,721.85 295,721.85 12.50 11.31 10.52% 10.17 9.61 8.51 3.3 2014 2013 (%) 2012 2011 2010 1.74 1.65 5.45% 1.49 1.22 1.41 1.74 1.65 5.45% 1.49 1.22 1.41 1.57 1.56 0.64% 1.34 1.16 1.33 (%) 14.66% 15.34% 0.68 15.17% 13.41% 17.94% (%) 13.96% 14.58% 0.62 14.68% 12.64% 16.61% (%) 50.62% 50.94% 0.32 53.39% 61.77% 68.75% 7

3.4 2014 2013 2012-999,029.93 180,148.18-69,242.34 362,000.00 66,827,495.36 38,842,657.52 42,064,456.38-1,497,131.42 499,437.51 18,086,042.35 636,406.43 1,688,027.35-1,001,272.08-435,271.79 66,019,361.36 38,882,971.13 60,282,391.03 9,666,588.14 7,150,619.26 8,151,476.68 3,405,813.53 6,389,185.80 6,649,649.17 52,946,959.69 25,343,166.07 45,481,265.18 1 8

4 4.1 4.1.1 5,544.234,618.68 20.04%553.62523.99 5.66%515.98 487.505.84%2014 463.03462.16 0.19% 9

4.1.2 2014 2014 (%) (%) (%) (%) 431,037,680.54 48,309,794.40 88.79% 20.17% 17.58% 0.25 156,759,171.09 37,145,130.55 76.30% 5.86% 5.13% 0.16 336,583,358.97 81,528,860.24 75.78% 20.55% 13.33% 1.55 750,123,661.00 268,389,602.81 64.22% 23.88% 31.38% 2.04 450,784,204.64 82,342,408.68 81.73% 44.92% 9.26% 5.96 1,739,731,105.27 372,565,292.41 78.58% 4.87% 12.36% 1.43 1,139,189,704.02 984,279,668.37 13.60% 42.65% 38.01% 2.91 440,787,403.63 193,250,926.60 56.16% 19.54% 18.64% 0.33 11,215,684.96 16,019,948.82 42.84% 72.40% 9.37% 99.33 5,456,211,974.12 2,083,831,632.88 61.81% 19.41% 26.04% 2.01 1,311,116,228.83 214,037,211.46 83.68% 2.62% 10.92% 1.22 4,979,167,204.77 1,682,696,490.71 66.21% 17.78% 22.45% 1.28 477,044,769.35 401,135,142.17 15.91% 39.48% 43.72% 2.48 5,456,211,974.12 2,083,831,632.88 61.81% 19.41% 26.04% 2.01 5,456.214,569.39 886.82 19.41% 42.65% 2,083.831,653.34 430.4926.04% 10

4,979,167,204.77 1,682,696,490.71 4,227,365,211.44 1,374,235,382.17 477,044,769.35 401,135,142.17 342,022,777.22 279,108,729.89 5,456,211,974.12 2,083,831,632.88 4,569,387,988.66 1,653,344,112.06 7.51%20137.56% 33.84%201327.39% 2,693.37 460.4120.62% 2014 2013 (%) 2,208,218,745.28 1,810,747,376.60 21.95% 464,522,751.34 437,293,065.57 6.23% 20,631,590.86 15,076,696.90 236.84% 11

(1) 21.95% (2) 6.23% (3) 236.84% 98.406.55 6.24% 290.022013 233.0624.44%7.85% 5.23% 15838 421 41 11 233 12

(1)II III IIa IIa(2) IaIb (rhcg)cd20 VeroCDE (3)PCR B19IgMB19 IgGIgM 20142 20132009 2014 2013 2014 13

2014 2014 327 300GAP 3502014 2200 37 118217.92 7230 12 14

4.1.3 450,000,000.00 2,163,648,794.34 1,309,770,401.19 141,840,556.30 149,000,000.00 630,723,547.77 567,309,401.60 90,047,696.80 61,561,014.73 723,192,591.55 467,014,592.21 102,854,627.68 87,328,900.00 247,078,637.99 169,258,861.90 42,129,177.68 128,280,000.00 613,287,821.60 214,264,254.80 17,815,136.65 15

134,925,200.00 371,836,894.22 253,750,795.52 29,353,091.08 USD41,700,000.00 511,232,257.37 412,322,206.40 18,494,221.28 HIV 46,450,837.00 469,993,492.10 302,326,464.60 85,603,683.30 500,000,000.00 314,553,681.00 292,432,635.02 45,476,858.07 65,000,000.00 30,356,175.19 13,823,041.36 11,922,711.76 16

4.2 4.2.1 2014 2013 (%) (%) (%) 6,423,571.77 0.09% 11,335,125.54 0.17% -43.33% 52,132,444.90 0.71% 39,477,295.95 0.60% 32.06% 847,479,822.39 11.61% 641,649,965.85 9.77% 32.08% 141,402,772.99 1.94% 92,294,668.60 1.41% 53.21% 2,943,569,643.19 40.31% 1,976,910,773.96 30.11% 48.90% 561,716,329.53 7.69% 1,082,419,104.88 16.49% -48.11% 121,472.17 0.00% 481,529.20 0.01% -74.77% 25,569,660.19 0.35% 13,914,408.10 0.21% 83.76% 65,254,992.11 0.89% 50,190,408.52 0.76% 30.01% 30% (1) 43.33% (2) 32.06% (3) 32.08%GMP (4) 53.21% 17

(5) 48.90% (6) 48.11% (7) 74.77% (8) 83.76% (9) 30.01% 4.2.2 2014 2013 (%) (%) (%) 598,748,939.78 8.20% 435,966,092.72 6.64% 37.34% 33,211,993.26 0.45% 89,414,763.31 1.36% -62.86% 5,049,329.12 0.07% 2,531,984.46 0.04% 99.42% 66,500,000.00 0.91% 149,900,000.00 2.28% -55.64% 7,241,263.39 0.10% 2,834,136.62 0.04% 155.50% 30% (1) 37.34% (2) 62.86% 18

(3) 99.42% (4) 55.64% (5) 155.50% 2014123120131231 2013123145.10% 2014123144.10% 4.2.3 2014 2013 (%) (%) (%) 20,631,590.86 0.28% -15,076,696.90-0.23% 236.84% -4,939,260.57-0.07% -1,236,410.63-0.02% -299.48% 8,223,836.93 0.11% 4,539,511.05 0.07% 81.16% 70,113,415.16 0.96% 43,108,434.91 0.66% 62.64% 2,596,922.38 0.04% 4,724,901.29 0.07% -45.04% 30% (1) 236.84% 19

(2) 299.48% (3) 81.16% (4) 62.64% (5) 45.04% 4.2.4 2014 2013 (%) (%) (%) 717,393,893.55 9.82% 439,986,525.69 6.70% 63.05% 29,024,256.39 0.40% 54,459,643.16 0.83% -46.71% -20,882,108.37-0.29% 7,766,397.47 0.12% -368.88% -41,814,307.14-0.57% -427,707,567.21-6.51% 90.22% 30% (1) 63.05% (2) 46.71% (3) 368.88% (4) 90.22% 20

4.2.5 20141231715.7120131231 761.04 20141231742.4220131231 640.9810.17%201312319.76%1 675.9220131231491.08 9.26%201312317.48%166.50 20131231149.900.91%20131231 2.28% 732.60 548.16 2013123145.10%2014123144.10% 4.2.6 20141231 4,082.423,220.187,302.60 2,669.17201312312,329.68 14.57%551.0120131231 631.8112.79%1,167.40 201312311,235.16 3,696.52201312313,344.65 10.52%385.9020131231 259.8748.50% 21

201420141231 201320131231 177,881.98 176,402.83 708,388,606.07 747,677,597.88 679,527,879.52 694,716,070.22 7,018,811.61 0.78887 5,536,929.91 39,298,550.07 0.78623 30,897,699.02 2,593,865.03 6.119 15,871,860.12 2,969,157.58 6.0969 18,102,656.85 105,263,476.00 0.051371 5,407,490.03 47,462,411.00 0.057771 2,741,950.95 28,511.82 7.4556 212,572.73 24,046.87 8.4189 202,448.19 2,357,320.50 0.7771 1,831,873.76 1,339,974.50 0.7588 1,016,772.65 7,139,115.75 13,190,134.83 715,705,603.80 761,044,135.54 4.2.7 2014 2013 26,855,257.66 9,063,185.39 32,627,626.68 41,723,173.32 59,482,884.34 50,786,358.71 22

4.2.8 476.53 4.2.9 20141231 4.2.10 20141231 2014 1231 69,091.76 6,522,085.87 6,591,177.63 23

4.2.11 201412315,544201312315,058 442.16 20131231374.31 4.2.12 2014415 Epirus Biopharmaceuticals, Inc.Epirus Epirus Biopharmaceuticals, Inc. B1,500 9,325.50Epirus1,181.10B Epirus15.22%2014716EpirusNASDAQ: EPRSEpirus156.60 Epirus 12.14% 2014924Epirus 5 24

4.3 4.4 (1) (2) 4000 25

(3) 9 15 (4) 2014123120GMP 15GMP14FDAFDA EU-GMPCEP4 26

4.5 (1) 2015 2015 2015 (2) 2015 2015 (3) A 27

(4) 2015 2015 (a) 2015 28

(b) 2015 20158 (c) 2015 EHS EHS EHSEHS 29

(d) 2015 (e) 2015 30

5 5.1 5.2 2014521 15,000,000.00 14,937,228.26 62,771.74 5.3 5.4 31

5.4.1 2014.12.31 2013.12.31 715,705,603.80 761,044,135.54 6,423,571.77 11,335,125.54 305,315,241.79 271,431,749.11 1 1,072,890,517.48 1,053,350,426.59 165,935,012.06 202,437,865.84 52,132,444.90 39,477,295.95 847,479,822.39 641,649,965.85 3,165,882,214.19 2,980,726,564.42 141,402,772.99 92,294,668.60 37,771,892.70 41,511,757.45 2,943,569,643.19 1,976,910,773.96 561,716,329.53 1,082,419,104.88 121,472.17 481,529.20 258,275,580.98 224,516,411.93 103,040,497.85 103,040,497.85 25,569,660.19 13,914,408.10 65,254,992.11 50,190,408.52 4,136,722,841.71 3,585,279,560.49 7,302,605,055.90 6,566,006,124.91 32

5.4.1 2014.12.31 2013.12.31 375,920,221.10 491,084,453.79 352,619,794.63 375,775,891.08 2 598,748,939.78 435,966,092.72 56,013,777.28 61,780,193.14 69,614,375.75 90,493,756.24 33,211,993.26 89,414,763.31 17,089,201.23 15,434,979.65 5,049,329.12 2,531,984.46 860,502,818.73 766,798,857.30 400,000.00 400,000.00 300,000,000.00 2,669,170,450.88 2,329,680,971.69 66,500,000.00 149,900,000.00 400,000,000.00 400,000,000.00 77,271,812.03 79,071,532.72 7,241,263.39 2,834,136.62 551,013,075.42 631,805,669.34 3,220,183,526.30 2,961,486,641.03 33

5.4.1 2014.12.31 2013.12.31 295,721,852.00 295,721,852.00 212,694,714.74 211,945,629.20 33,326,810.31 16,328,209.99 513,472,484.27 501,196,946.97 2,707,954,326.83 2,352,112,358.31 3,696,516,567.53 3,344,648,576.49 385,904,962.07 259,870,907.39 4,082,421,529.60 3,604,519,483.88 7,302,605,055.90 6,566,006,124.91 34

5.4.2 5,544,233,777.86 4,618,680,040.86 3 5,544,233,777.86 4,618,680,040.86 4,963,009,813.13 4,031,426,221.20 3 2,142,911,022.41 1,694,615,109.00 4 69,192,335.88 58,522,104.24 2,208,218,745.28 1,810,747,376.60 464,522,751.34 437,293,065.57 20,631,590.86 15,076,696.90 57,533,367.36 45,325,262.69 4,939,260.57 1,236,410.63 8,223,836.93 4,539,511.05 4,781,707.78 2,803,662.91 584,508,541.09 590,556,920.08 5 70,113,415.16 43,108,434.91 355,242.11 359,811.57 2,596,922.38 4,724,901.29 1,354,272.04 179,663.39 652,025,033.87 628,940,453.70 6 98,402,861.09 104,953,936.07 553,622,172.78 523,986,517.63 515,978,431.82 487,502,351.80 37,643,740.96 36,484,165.83 35

31,281,778.71 2,765,356.39 16,998,600.32 2,748,485.94 1 2 16,998,600.32 2,748,485.94 1 2 17,246,053.09 485,604.92 3 4 5 247,452.77 2,262,881.02 6 14,283,178.39 16,870.45 522,340,394.07 521,221,161.24 498,979,831.50 484,753,865.86 23,360,562.57 36,467,295.38 7 1.74 1.65 7 1.74 1.65 36

5.4.3 5,734,733,028.52 4,456,512,759.42 34,804,053.19 18,024,648.66 116,438,994.13 139,596,652.32 5,885,976,075.84 4,614,134,060.40 1,631,606,641.93 1,283,593,895.13 421,094,103.74 375,282,809.41 769,748,289.54 637,719,137.22 2,346,133,147.08 1,877,551,692.95 5,168,582,182.29 4,174,147,534.71 717,393,893.55 439,986,525.69 10,181,993.32 46,531,879.23 4,167,796.06 891,519.24 2,830,255.60 186,298.00 11,844,211.41 6,849,946.69 29,024,256.39 54,459,643.16 665,519,169.35 920,001,234.77 93,254,995.09 460,000.00 8,255,955.14 8,563,590.71 767,030,119.58 929,024,825.48 738,005,863.19 874,565,182.32 37

98,000,000.00 51,500,000.00 98,000,000.00 51,500,000.00 964,948,392.37 947,017,564.37 300,000,000.00 400,000,000.00 40,666,343.14 1,362,948,392.37 1,439,183,907.51 1,167,396,663.73 1,235,160,644.60 216,433,837.01 192,256,865.44 17,150,000.00 4,000,000.00 1,383,830,500.74 1,431,417,510.04 20,882,108.37 7,766,397.47 320,229.13 895,308.05 41,814,307.14 427,707,567.21 750,928,733.31 1,178,636,300.52 709,114,426.17 750,928,733.31 5.4.4 5.4.5 2014111231201311 12312014123120131231 38

1 3090 (%) (%) 190 892,939,631.57 78.64 915,319,753.14 82.11 91180 177,228,210.75 15.61 118,197,408.04 10.60 1811 37,037,363.34 3.26 42,671,189.41 3.83 12 15,959,104.30 1.41 28,363,181.65 2.54 23 6,833,675.62 0.60 4,774,679.92 0.43 34 1,772,481.41 0.16 1,419,854.38 0.13 45 582,321.27 0.05 988,105.44 0.09 5 3,050,834.85 0.27 3,080,930.73 0.27 1,135,403,623.11 100.00 1,114,815,102.71 100.00 62,513,105.63 61,464,676.12 1,072,890,517.48 1,053,350,426.59 2 190 327,211,277.75 332,078,144.46 91180 89,161,459.34 22,789,943.67 1811 117,872,097.04 41,623,708.26 12 43,392,010.73 30,018,248.59 2 21,112,094.92 9,456,047.74 598,748,939.78 435,966,092.72 39

3 5,456,211,974.12 2,083,831,632.88 4,569,387,988.66 1,653,344,112.06 88,021,803.74 59,079,389.53 49,292,052.20 41,270,996.94 5,544,233,777.86 2,142,911,022.41 4,618,680,040.86 1,694,615,109.00 4 37,297,910.45 31,662,997.86 29,191,576.91 24,476,705.48 2,460,143.73 2,007,783.14 241,648.46 82,581.51 1,056.33 292,036.25 69,192,335.88 58,522,104.24 40

5 355,242.11 359,811.57 355,242.11 355,242.11 359,811.57 355,242.11 1,214,462.30 953,579.28 1,214,462.30 66,827,495.36 38,842,657.52 66,827,495.36 252,832.99 902,665.59 252,832.99 455,033.39 1,106,716.51 455,033.39 1,008,349.01 943,004.44 1,008,349.01 70,113,415.16 43,108,434.91 70,113,415.16 6 (1) 98,913,586.15 111,641,150.16 99,487,636.19 110,948,465.11 574,050.04 692,685.05 510,725.06 6,687,214.09 98,402,861.09 104,953,936.07 41

(2) 652,025,033.87 628,940,453.70 163,006,258.47 157,235,113.43 1,207,474.59 678,758.33-78,318,844.13 76,372,494.55 3,435,633.78 2,099,603.18 5,358,514.01 9,071,931.33 16,877,054.00 10,336,882.08 4,121,151.17 673,122.56 1,674,949.56 2,577,264.83 98,402,861.09 104,953,936.07 7 (1) 1.74 1.74 1.65 1.65 1.57 1.57 1.56 1.56 42

(2) A 515,978,431.82 487,502,351.80 B 52,946,959.69 25,343,166.07 C=A-B 463,031,472.13 462,159,185.73 D 295,721,852 295,721,852 E 0.00 0.00 F 0.00 0.00 G 0.00 0.00 H 0.00 0.00 I 0.00 0.00 J 0.00 0.00 K 12 12 L=D+E+F*G/ 295,721,852 295,721,852 K-H*I/K-J M=A/L 1.74 1.65 N=C/L 1.57 1.56 43

8 (1) 3,165,882,214.19 2,980,726,564.42 2,669,170,450.88 2,329,680,971.69 496,711,763.31 651,045,592.73 (2) 7,302,605,055.90 6,566,006,124.91 2,669,170,450.88 2,329,680,971.69 4,633,434,605.02 4,236,325,153.22 9 1,341,472,057.40 228,074,392.73 20,321,156.24 1,549,225,293.89 166,178,628.39 19,040,602.87 0.00 185,219,231.26 44

10 20142014 10 12013105 1032013295,721,852 29,572,185.202013147,860,926 88,716,555.602013 6 H2014116H20141231 7 H20141231 45

8 H20141231 H2014 1231 9 20141231 10 20142014 10 1.00103 295,721,852 29,572,185.2088,716,555.60 46

11 H H Livzon Pharmaceutical Group Inc. * * 47